Professional Squash Association World Tour uses MEDsan UK’s rapid antigen tests

Case Study  -  May 20th 2021

Professional Squash Association World Tour uses MEDsan UK’s rapid antigen tests

As The Professional Squash Association (PSA) prepares for the forthcoming El Gouna International Squash Open, held from 20-28th May in Egypt, coronavirus safety measures are front and centre of planning. Part of the PSA World Series, the El Gouna International is at the highest level of professional squash competitions, with 96 male and female squash superstars lined up to compete.

The PSA is forming an event bubble – consisting of players, referees, event staff and TV production crews, and will be implementing rapid coronavirus antigen testing from MEDsan UK to ensure the bubble stays free from infection throughout the tournament. Appropriate measures will be taken following any positive result, including amending scheduling and following isolation guidelines.

Having utilised PCR testing throughout previous competitions, the PSA has opted for the more practical option of rapid lateral flow tests for the testing during the event in El Gouna. A negative PCR test is required before arrival in Egypt, with a further one required to enter the event bubble after which a rapid antigen testing will be used as an additional safety measure to ensure all those involved are free from infection throughout their time at the tournament.

MEDsan UK’s rapid antigen tests can be taken on site, on the day of competition, with results generated within just 20 minutes – making it a manageable and practical method to test the event bubble. MEDsan’s rapid antigen test is manufactured in Germany, with a clinical sensitivity of 92.5%.

Tim Garner, Event Director of the PSA, said: “Conducting rapid antigen tests at the events are a crucial measure to ensuring our competition can continue safely. It is important to pick up any infections as quickly as possible to keep the bubble secure and rapid antigen testing gives us immediate assurances that the players and those in the event bubble have not contracted coronavirus and are safe to participate in the competition.”

In addition to the testing protocol, the PSA is following a range of coronavirus countermeasures, including keeping the event bubble separated and distanced from those outside, both at venues and hotels, for the duration of the competition.

Paul Hillman, CEO of MEDsan UK, said: “Rapid antigen testing is the only means to reduce the risk to the elite sports community’s professionals and the fans who support them. We’re proud to help PSA get back to competition after this disruptive time for global sport. The PSA are a leading example of how to run international tournaments as safely as possible.”